Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

Project: Other project

Project Details

StatusFinished
Effective start/end date6/1/17 → 5/31/22

Funding

  • National Inst of Allergy & Infectious Di: $3,061,253.00